Sanofi SA (NASDAQ:SNY) reported Thursday a first-quarter 2025 business operating income of 2.9 billion euros ($3.06 billion), up 20.1% year over year and 18.7% in constant currency. The company ...

Pharmaceutical and healthcare company Sanofi SA (NASDAQ:SNY) has announced the purchase of 2.3% of its shares from its long-standing investor, L’Oréal SA (OTC:LRLCF), as part of its ongoing share ...

French pharmaceutical major Sanofi SA (SNY) said on Thursday that it would acquire U.S.-based Vigil Neuroscience, Inc. (VIGL) for about $470 million. Vigil is a clinical-stage biotechnology company ...

Investing.com -- Sanofi SA (EPA:SASY) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application of tolebrutinib, which was ...

Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved ...

Sanofi SA reported more hitches in the development of Bruton’s tyrosine kinase inhibitor tolebrutinib, saying the phase III Perseus study failed to meet its primary endpoint in primary progressive ...

Sanofi SA gained U.S. FDA approval for fitusiran as a first-in-class siRNA therapy for hemophilia. Branded Qfitlia, the antithrombin-lowering therapy is indicated for use as a prophylactic treatment ...

France-based Sanofi S.A. (FR:SAN) is expanding its presence in China with an investment of €1 billion to build a new insulin manufacturing plant in Beijing. This represents Sanofi’s largest-ever ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...

French drugmaker Sanofi SA said Wednesday that it's reorganizing research operations in the U.S. and planning to trim its sales force for the second time in barely a year as it aims to boost ...

PARIS – The regimen of recommended vaccine shots for elderly Americans may soon be simplified. The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination ...